TrialThe international journal of neuropsychopharmacology2023

Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia.

Dean Najarian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.